Protected Anti-Infectives

Policy HS 1444→

HOW APPROVAL WORKS

  1. 1Request a formal Infectious Diseases consultation. Document the indication at order entry.
  2. 2The ID physician sees the patient and gives verbal or written approval.
  3. 3Pharmacy dispenses scheduled doses.

ORDERED AFTER HOURS (5 PM – 10 AM)

Pharmacy dispenses enough drug to last until the next day, with no consult needed. The pharmacist tells the prescriber the approval is temporary.

The ordering team must then get an ID consult to receive further doses.

All require Infectious Diseases consultation unless noted. NF FORM = Request for Non-Formulary Medication form required. EXCEPTION = consult not always required.

AGENT CRITERIA
A
Amphotericin B deoxycholateConventional Does not apply to amphotericin B lock therapy.
Amphotericin B, liposomalAmBisome —
Artesunate Reserved for SEVERE malaria: ≥ 5% parasitemia; evidence of end-organ damage; impaired consciousness / coma; hemoglobin < 7 g/dL; circulatory collapse / shock, acidosis; disseminated intravascular coagulation.
B
Baloxavir marboxilXofluza Case-by-case treatment of refractory documented influenza A or B in patients who failed conventional treatment (oseltamivir or peramivir).
BedaquilineNon-formularyNF FORM Request for Non-Formulary Medication form must be completed. Reserved for multi-drug resistant tuberculosis (MDR TB) or other highly resistant mycobacterial infections, case by case.
C
Cefiderocol Reserved for infections caused by documented MDR/CRE organisms, or a RECENT history of MDR/CRE infection, as salvage therapy to other beta-lactam/beta-lactamase inhibitors.
Ceftaroline —
Ceftazidime/avibactam Reserved for a DOCUMENTED susceptible MDR/carbapenem-resistant (CRE) organism or a RECENT history of MDR/CRE infection.
Ceftolozane/tazobactam Reserved for a DOCUMENTED susceptible multi-drug resistant (MDR) organism or a RECENT history of MDR infection.
Cidofovir —
Colistimethate sodiumColistin Reserved for a documented susceptible multi-drug resistant (MDR) organism or a RECENT history of MDR infection.
D
DalbavancinEXCEPTION ID must approve dalbavancin before initiation.
Exception: no ID consult needed in the ED if the patient meets both criteria:
  • Candidate for ≥ 24 h of IV antibiotics and “ineligible” for oral antibiotics
  • Infection highly suspected to be gram-positive (Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus spp., Streptococcus spp.)
“Ineligible” for oral antibiotics means any of:
  • History of medication adherence issues
  • No stable housing, so medication security is a concern
  • Cannot absorb oral antibiotics
  • Source control not achieved, and the patient cannot complete usual IV therapy because of patient-directed discharge
  • Source control not achieved, and the patient cannot be discharged to SNF or home on IV antibiotics for psychosocial reasons such as substance use disorder
DaptomycinEXCEPTION Exception: no ID consult needed for a single dose in patients discharged from the ED to Next Day Clinic for skin and soft tissue or diabetic foot infections.
E
Eravacycline —
Ethambutol —
F
Fecal microbiota (live)Rebyota® rectal · Vowst® oral ID consultation by Drs Daniel Uslan or Otto Yang. Prescribed by an adult or pediatric ID provider within their ambulatory ID clinic. The inpatient ordering workflow is in Firstline – Clinical Decisions.
Indicated for more than one recurrent C. difficile infection (CDI) after a primary episode. Give 24–72 h after the last dose of a CDI-directed antibiotic regimen.
Foscarnet —
I
Imipenem/cilastatin Primary indication: nontuberculous mycobacterial infections.
Imipenem/cilastatin/relebactamNon-formularyNF FORM Request for Non-Formulary Medication form must be completed. Reserved for a DOCUMENTED susceptible MDR/CRE organism or a RECENT history of MDR/CRE infection. Requires documented resistance to ceftazidime/avibactam and meropenem/vaborbactam.
Isavuconazole sulfateEXCEPTION No ID consult needed for antifungal prophylaxis in patients with hematologic malignancies or undergoing transplant.
L
LetermovirFormulary for HSCT · non-formulary otherwiseNF FORM ID consult and a Non-Formulary Medication Request form are required outside these populations: adult CMV-seropositive [R+] allogeneic hematopoietic stem cell transplant recipients; [D+/R-] kidney transplant recipients. Only approved for CMV prophylaxis in high-risk patients with contraindications to formulary antivirals.
M
MaribavirNon-formularyNF FORM ID consult and a Non-Formulary Medication Request form are required PRIOR to initiation. Reserved for CMV infection caused by isolates resistant and/or refractory to first-line agents. Patient Access and Support is available.
Meropenem/vaborbactamVabomere Reserved for a documented MDR/CRE organism or a RECENT history of MDR/CRE infection.
MicafunginEXCEPTION ID consult required after 72 hours of treatment. Not required for prophylaxis in solid organ or bone marrow transplant patients.
MinocyclineIV only Reserved for documented carbapenem-resistant Enterobacterales or Stenotrophomonas.
Moxifloxacin Reserved for documented moxifloxacin-susceptible nontuberculous mycobacterial infection.
P
PentamidineInhaled —
PlazomicinZemdri Reserved for a documented susceptible multi-drug resistant (MDR) organism or a RECENT history of MDR infection.
Polymyxin B Reserved for a documented susceptible multi-drug resistant (MDR) organism or a RECENT history of MDR infection.
Pyrazinamide —
R
RibavirinInhaled · non-formularyNF FORM Request for Non-Formulary Medication form must be completed. After approval, the ordering provider must notify the Director of Safety at the time of prescription.
S
Sulbactam/durlobactamXacduro® —
T
Tigecycline Because serum concentrations are poor, avoid tigecycline or use it with caution for endovascular infections.

33 agents · scroll the table for more

PRESCRIBING PRINCIPLES: ALL ANTI-INFECTIVES

  • Prescribe the right drug, dose, and duration to maximize benefit while minimizing toxicity and resistance.
  • Review empiric therapy at 48–72 h (“antibiotic time out”), then follow microbiology and the clinical course.
  • Document the indication in the medical record for every prescription.
  • Follow UCLA treatment recommendations and the local susceptibility summary on the ASP website or in the Firstline – Clinical Decisions app.

POLICY RULES: PROTECTED AGENTS

  • Applies to all patients at all designated UCLA Health System hospitals.
  • After the first doses, the ordering team is responsible for getting ID consultation for continued therapy.
  • Using an ID physician’s name on an order without their approval violates hospital policy.
  • Use is audited by the ASP and reported to hospital committees.
  • During a CRITICAL shortage, the P&T Committee Chair or ASP Director(s) may temporarily add the affected agent to this policy.

FDA Drug Shortages

Updated 10/17/26

Shortages that affect UCLA guidelines, with what to use instead.

SHORT DRUG   USE INSTEAD GUIDANCE
Azithromycin IV PO azithromycin · Doxycycline Give it PO once the patient takes pills, and stop at day 3 in CAP without suspected Legionella. Doxycycline covers atypicals.
Clindamycin IV Linezolid Rarely needed. Can use linezolid for toxin inhibition in necrotizing fasciitis.
Vancomycin and linezolid IV De-escalate · PO linezolid Stop vancomycin at 48 h if the MRSA nasal PCR is negative. Linezolid PO is fully bioavailable, so switch as soon as the gut works.
Levofloxacin and moxifloxacin IV Same drug PO Both are fully bioavailable orally. Reserve IV fluoroquinolones for patients with GI absorption issues or who cannot take orals, and only when there are no alternatives.
Bicillin L-A Doxycycline · Lentocilin (import) Save it for pregnancy, congenital syphilis, and patients who can't take doxycycline. FDA is letting in imported Lentocilin. See the penicillin note below.
PRE-PEN(penicillin skin test) Oral amoxicillin challenge For low-risk histories, go straight to an oral amoxicillin challenge. See the allergy pathway.

NOTE ON PENICILLIN

Penicillin is still the narrowest, most effective option for several syndromes, so choose substitutes on purpose, not by default.

  • Reserve Bicillin L-A for pregnant patients with syphilis and infants with congenital syphilis. These groups have no equivalent alternative.
  • Documented allergy, not pregnant: doxycycline is an acceptable substitute.
  • Everyone else: clarify the allergy or test for it. Don't default to a broader agent.

Before changing a regimen, confirm product availability in the ASHP shortage bulletins and with Pharmacy.

Shortage information reflects FDA and ASHP postings and UCLA Health supply as of the date shown. Confirm availability with Pharmacy before prescribing.